Rituximab treatment may disturb the normal pattern of lymphopoiesis after cord blood SCT

Bone Marrow Transplant. 2012 Mar;47(3):458-60. doi: 10.1038/bmt.2011.98. Epub 2011 May 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Female
  • Fetal Blood / cytology*
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Immunologic Factors / therapeutic use
  • Lymphopoiesis / drug effects*
  • Male
  • Middle Aged
  • Risk Factors
  • Rituximab
  • Syndrome
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab